» Articles » PMID: 39340169

The Focus on Life-prolonging Anticancer Treatment Hampers Shared Decision-making in People with Advanced Cancer: A Qualitative Embedded Multiple-case Study

Abstract

Background: Implementing shared decision-making in oncology practice is often limited, particularly integrating the patient's context into decision-making. To improve this, we conducted a quality improvement project, attempts to accomplish this by: (1) Integrating the patient's context into shared decision-making during consultation with the medical oncologist; (2) Actively involving the GP and case manager (a specialized oncology nurse), who often have knowledge about the patient's context, and; (3) Giving the person with advanced cancer a time-out period of up to 2 weeks to consider and discuss treatment options with others, including close family and friends.

Aim: To explore how persons with advanced cancer and their involved professionals experienced shared decision-making after the introduction of .

Design: A qualitative embedded multiple-case study using in-depth interviews analysed with inductive content analysis.

Participants: A purposive sample of 14 cases, each case consisting of a patient with advanced cancer and ideally their medical oncologist, case manager, and GP.

Results: Four themes were identified: shared decision-making is a dynamic and continuous process (1), in which the medical oncologist's treatment recommendation is central (2), fuelled by the patients' experience of not having a choice (3), and integrating the patient's context into shared decision-making was considered important but hampered (4), for example, by the association with the terminal phase.

Conclusions: The prevailing tendency among medical oncologists and persons with advanced cancer to prioritize life-prolonging anticancer treatments restricts the potential for shared decision-making. This undermines integrating individual context into decision-making, a critical aspect of the palliative care continuum.

References
1.
Elwyn G, Durand M, Song J, Aarts J, Barr P, Berger Z . A three-talk model for shared decision making: multistage consultation process. BMJ. 2017; 359:j4891. PMC: 5683042. DOI: 10.1136/bmj.j4891. View

2.
Wieldraaijer T, de Meij M, Zwaard S, van Weert H, Wind J . Introducing a time out consultation with the general practitioner between diagnosis and start of colorectal cancer treatment: Patient-reported outcomes. Eur J Cancer Care (Engl). 2019; 28(6):e13141. PMC: 7074010. DOI: 10.1111/ecc.13141. View

3.
Weiner S . Contextualizing medical decisions to individualize care: lessons from the qualitative sciences. J Gen Intern Med. 2004; 19(3):281-5. PMC: 1492155. DOI: 10.1111/j.1525-1497.2004.30261.x. View

4.
Brom L, Pasman H, Widdershoven G, van der Vorst M, Reijneveld J, Postma T . Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients. PLoS One. 2014; 9(6):e100435. PMC: 4070976. DOI: 10.1371/journal.pone.0100435. View

5.
Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View